Bristol-Myers Squibb Company

Location

New Jersey

Founded

1887-04-10

Website

https://www.bms.com

Risk Signals

10468 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Corporate Insolvency Insolvency Risks Tax Compliance Violations Asset Seizure Workforce Reductions Ethics Violations Allegations Financial Reporting Irregularities Insider Trading Violations Explosion and Gas Leak Incidents Fire Incident Impact Logistics & Transportation Disruptions Illicit Financial Practices Offshore Tax Practices Legal Scandals Labor Exploitation Government Corruption Product Quality Compliance Safety Compliance Violations Product Recall Regulatory and Legal Emergencies Corporate Fraud Corporate Financial Crises Fraud Investigations Child Labor Violations Financial Crime Investigations Financial Statement Revisions Debt Strategy and Obligations Activist Short Selling Investor Sentiment Trends War

Recent Articles about Bristol-Myers Squibb Company

Live alerts from global media, monitored by Business Radar

Bristol-Myers Squibb Files Investor Presentation and Board of Directors Sends Letter to Shareholders Regarding Pending Transaction with Celgene

2019-03-06 (businesswire.com)

Bristol-Myers Squibb Files Investor Presentation and Board of Directors Sends Letter to Shareholders Regarding Pending Transaction with Celgene

Bristol-Myers Squibb Company (NYSE:BMY) today filed an investor presentation with the Securities and Exchange Commission (SEC), and the Board of Direc

Read more
Drug executives face U.S. lawmakers on high prices of prescriptions | WGXA

2019-02-26 (wgxa.tv)

Drug executives face U.S. lawmakers on high prices of prescriptions | WGXA

From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President,

Read more
Drug executives face U.S. lawmakers on high prices of prescriptions | WGXA

2019-02-26 (wgxa.tv)

Drug executives face U.S. lawmakers on high prices of prescriptions | WGXA

From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President,

Read more
INNATE PHARMA: Financial information for the first quarter of 2017 | Analist.be

2017-05-15 (analist.be)

INNATE PHARMA: Financial information for the first quarter of 2017 | Analist.be

INNATE PHARMA: Financial information for the first quarter of 2017 | Analist.be

Read more
INNATE PHARMA: Financial results for the first half of 2016 | Analist.be

2016-09-08 (analist.be)

INNATE PHARMA: Financial results for the first half of 2016 | Analist.be

INNATE PHARMA: Financial results for the first half of 2016 | Analist.be

Read more

Never miss a headline about Bristol-Myers Squibb Company

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages